Structure

Physi-Chem Properties

Molecular Weight:  204.04
Volume:  201.042
LogP:  1.804
LogD:  1.555
LogS:  -2.854
# Rotatable Bonds:  1
TPSA:  63.6
# H-Bond Aceptor:  4
# H-Bond Donor:  1
# Rings:  2
# Heavy Atoms:  4

MedChem Properties

QED Drug-Likeness Score:  0.748
Synthetic Accessibility Score:  2.297
Fsp3:  0.091
Lipinski Rule-of-5:  Accepted
Pfizer Rule:  Accepted
GSK Rule:  Accepted
BMS Rule:  0
Golden Triangle Rule:  Accepted
Chelating Alert:  0
PAINS Alert:  1

ADMET Properties (ADMETlab2.0)

ADMET: Absorption

Caco-2 Permeability:  -4.635
MDCK Permeability:  2.3473627152270637e-05
Pgp-inhibitor:  0.008
Pgp-substrate:  0.001
Human Intestinal Absorption (HIA):  0.007
20% Bioavailability (F20%):  0.301
30% Bioavailability (F30%):  0.466

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):  0.375
Plasma Protein Binding (PPB):  94.1186752319336%
Volume Distribution (VD):  0.468
Pgp-substrate:  2.1840171813964844%

ADMET: Metabolism

CYP1A2-inhibitor:  0.982
CYP1A2-substrate:  0.809
CYP2C19-inhibitor:  0.652
CYP2C19-substrate:  0.086
CYP2C9-inhibitor:  0.663
CYP2C9-substrate:  0.77
CYP2D6-inhibitor:  0.854
CYP2D6-substrate:  0.269
CYP3A4-inhibitor:  0.709
CYP3A4-substrate:  0.167

ADMET: Excretion

Clearance (CL):  8.138
Half-life (T1/2):  0.647

ADMET: Toxicity

hERG Blockers:  0.014
Human Hepatotoxicity (H-HT):  0.586
Drug-inuced Liver Injury (DILI):  0.572
AMES Toxicity:  0.928
Rat Oral Acute Toxicity:  0.947
Maximum Recommended Daily Dose:  0.874
Skin Sensitization:  0.855
Carcinogencity:  0.881
Eye Corrosion:  0.116
Eye Irritation:  0.982
Respiratory Toxicity:  0.506

Download Data

Data Type Select
General Info & Identifiers & Properties  
Structure MOL file  
Source Organisms  
Biological Activities  
Similar NPs/Drugs  

  Natural Product: NPC51037

Natural Product ID:  NPC51037
Common Name*:   3-Methoxyjuglone
IUPAC Name:   8-hydroxy-2-methoxynaphthalene-1,4-dione
Synonyms:   3-Methoxyjuglone
Standard InCHIKey:  HOFSOQDUZIZMBA-UHFFFAOYSA-N
Standard InCHI:  InChI=1S/C11H8O4/c1-15-9-5-8(13)6-3-2-4-7(12)10(6)11(9)14/h2-5,12H,1H3
SMILES:  COC1=CC(=O)c2cccc(c2C1=O)O
Synthetic Gene Cluster:   n.a.
ChEMBL Identifier:   CHEMBL2204407
PubChem CID:   609303
Chemical Classification**:  
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0002448] Benzenoids
      • [CHEMONTID:0000023] Naphthalenes
        • [CHEMONTID:0000153] Naphthoquinones

*Note: the InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
**Note: the Chemical Classification was calculated by NPClassifier Version 1.5. Reference: PMID:34662515.

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO20411 Engelhardia roxburghiana Species Juglandaceae Eukaryota n.a. n.a. n.a. Database[TCMID]
NPO20411 Engelhardia roxburghiana Species Juglandaceae Eukaryota n.a. n.a. n.a. Database[UNPD]

☑ Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  NP Quantity Composition/Concentration

Organism ID NP ID Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

☑ Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  Biological Activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT165 Cell Line HeLa Homo sapiens IC50 = 960.0 nM PMID[490378]
NPT165 Cell Line HeLa Homo sapiens IC50 = 1040.0 nM PMID[490378]
NPT165 Cell Line HeLa Homo sapiens INCC50 = 0.61 uM PMID[490378]
NPT165 Cell Line HeLa Homo sapiens Ratio = 1.7 n.a. PMID[490378]
NPT407 Cell Line COLO 205 Homo sapiens IC50 > 10000.0 nM PMID[490379]
NPT396 Cell Line T47D Homo sapiens IC50 > 10000.0 nM PMID[490379]
NPT111 Cell Line K562 Homo sapiens IC50 > 10000.0 nM PMID[490379]
NPT790 Organism Mycobacterium tuberculosis H37Rv Mycobacterium tuberculosis H37Rv MIC = 3.125 ug.mL-1 PMID[490377]
NPT27 Others Unspecified IC50 = 1480.0 nM PMID[490378]

☑ Note for Activity Records:
☉ The quantitative biological activities were primarily integrated from ChEMBL (Version-30) database and were also directly collected from PubMed literature. PubMed PMID was provided as the reference link for each activity record.

  Chemically structural similarity: I. Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes 4,3285 NPs with experimentally-derived bioactivity available in NPASS)

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient

●  The left chart: Distribution of similarity level between NPC51037 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).

Similarity Score Similarity Level Natural Product ID
0.9835 High Similarity NPC237225
0.9672 High Similarity NPC165257
0.9516 High Similarity NPC198305
0.9504 High Similarity NPC310540
0.9291 High Similarity NPC171968
0.9213 High Similarity NPC309430
0.9194 High Similarity NPC231774
0.9134 High Similarity NPC205360
0.9091 High Similarity NPC285829
0.9091 High Similarity NPC206778
0.9084 High Similarity NPC173980
0.9076 High Similarity NPC108288
0.904 High Similarity NPC1991
0.9008 High Similarity NPC232178
0.8992 High Similarity NPC254603
0.8952 High Similarity NPC135062
0.8889 High Similarity NPC306765
0.8872 High Similarity NPC477408
0.8871 High Similarity NPC307174
0.8828 High Similarity NPC278928
0.878 High Similarity NPC7151
0.878 High Similarity NPC473662
0.878 High Similarity NPC216297
0.8769 High Similarity NPC477406
0.8769 High Similarity NPC88864
0.874 High Similarity NPC3224
0.8731 High Similarity NPC114620
0.8731 High Similarity NPC103337
0.8712 High Similarity NPC22222
0.8712 High Similarity NPC281513
0.8702 High Similarity NPC193169
0.8678 High Similarity NPC240163
0.8661 High Similarity NPC287473
0.8651 High Similarity NPC375356
0.8626 High Similarity NPC242358
0.8626 High Similarity NPC246693
0.8626 High Similarity NPC110609
0.8615 High Similarity NPC117609
0.8615 High Similarity NPC199253
0.8615 High Similarity NPC136588
0.8615 High Similarity NPC475741
0.8615 High Similarity NPC27659
0.8607 High Similarity NPC477453
0.8605 High Similarity NPC179898
0.8594 High Similarity NPC96915
0.8583 High Similarity NPC234890
0.8583 High Similarity NPC74507
0.8571 High Similarity NPC164947
0.8571 High Similarity NPC300274
0.8551 High Similarity NPC477409
0.8538 High Similarity NPC34414
0.8538 High Similarity NPC146647
0.8537 High Similarity NPC269414
0.8527 High Similarity NPC45537
0.8527 High Similarity NPC470841
0.8525 High Similarity NPC161304
0.8516 High Similarity NPC103540
0.8507 High Similarity NPC232996
0.8504 High Similarity NPC182646
0.8485 Intermediate Similarity NPC17843
0.8485 Intermediate Similarity NPC70622
0.8473 Intermediate Similarity NPC55949
0.8468 Intermediate Similarity NPC41567
0.8462 Intermediate Similarity NPC247250
0.8462 Intermediate Similarity NPC767
0.8462 Intermediate Similarity NPC282923
0.8444 Intermediate Similarity NPC284184
0.8444 Intermediate Similarity NPC301341
0.8438 Intermediate Similarity NPC68756
0.8438 Intermediate Similarity NPC152525
0.8438 Intermediate Similarity NPC142956
0.8425 Intermediate Similarity NPC46634
0.8425 Intermediate Similarity NPC217756
0.8421 Intermediate Similarity NPC52407
0.8417 Intermediate Similarity NPC29932
0.8409 Intermediate Similarity NPC205992
0.8409 Intermediate Similarity NPC244699
0.8403 Intermediate Similarity NPC224584
0.8397 Intermediate Similarity NPC99731
0.8387 Intermediate Similarity NPC125252
0.8385 Intermediate Similarity NPC471530
0.837 Intermediate Similarity NPC86524
0.837 Intermediate Similarity NPC38158
0.837 Intermediate Similarity NPC141934
0.8369 Intermediate Similarity NPC476821
0.8359 Intermediate Similarity NPC477153
0.8358 Intermediate Similarity NPC50924
0.8357 Intermediate Similarity NPC474630
0.8346 Intermediate Similarity NPC478190
0.8333 Intermediate Similarity NPC84273
0.8333 Intermediate Similarity NPC110810
0.8333 Intermediate Similarity NPC283292
0.8333 Intermediate Similarity NPC31799
0.8321 Intermediate Similarity NPC476477
0.8321 Intermediate Similarity NPC256463
0.8321 Intermediate Similarity NPC306835
0.8321 Intermediate Similarity NPC299405
0.8321 Intermediate Similarity NPC471602
0.8321 Intermediate Similarity NPC111422
0.8321 Intermediate Similarity NPC216312
0.8321 Intermediate Similarity NPC48248
0.8321 Intermediate Similarity NPC29771
0.8319 Intermediate Similarity NPC34715
0.8308 Intermediate Similarity NPC15837
0.8306 Intermediate Similarity NPC325646
0.8306 Intermediate Similarity NPC28951
0.8298 Intermediate Similarity NPC136878
0.8295 Intermediate Similarity NPC265910
0.8295 Intermediate Similarity NPC91475
0.8295 Intermediate Similarity NPC474766
0.8284 Intermediate Similarity NPC225051
0.8284 Intermediate Similarity NPC53896
0.8279 Intermediate Similarity NPC231717
0.8261 Intermediate Similarity NPC42262
0.8261 Intermediate Similarity NPC147542
0.8261 Intermediate Similarity NPC241349
0.8261 Intermediate Similarity NPC156872
0.8261 Intermediate Similarity NPC327916
0.8261 Intermediate Similarity NPC32749
0.8261 Intermediate Similarity NPC220496
0.8261 Intermediate Similarity NPC37992
0.8248 Intermediate Similarity NPC61590
0.8244 Intermediate Similarity NPC473787
0.8239 Intermediate Similarity NPC252208
0.8235 Intermediate Similarity NPC315275
0.8235 Intermediate Similarity NPC155211
0.8235 Intermediate Similarity NPC474311
0.8231 Intermediate Similarity NPC123506
0.8227 Intermediate Similarity NPC28632
0.8222 Intermediate Similarity NPC288089
0.8211 Intermediate Similarity NPC11824
0.8209 Intermediate Similarity NPC58685
0.8203 Intermediate Similarity NPC198336
0.8201 Intermediate Similarity NPC257003
0.8201 Intermediate Similarity NPC124365
0.8201 Intermediate Similarity NPC471444
0.8195 Intermediate Similarity NPC147757
0.8188 Intermediate Similarity NPC1268
0.8188 Intermediate Similarity NPC26924
0.8188 Intermediate Similarity NPC295339
0.8188 Intermediate Similarity NPC52358
0.8182 Intermediate Similarity NPC95537
0.8175 Intermediate Similarity NPC305060
0.8175 Intermediate Similarity NPC264022
0.8175 Intermediate Similarity NPC471452
0.8175 Intermediate Similarity NPC477534
0.8168 Intermediate Similarity NPC136342
0.8168 Intermediate Similarity NPC295202
0.8168 Intermediate Similarity NPC160499
0.8168 Intermediate Similarity NPC49647
0.8168 Intermediate Similarity NPC227741
0.8162 Intermediate Similarity NPC283088
0.8162 Intermediate Similarity NPC80035
0.8162 Intermediate Similarity NPC161632
0.8156 Intermediate Similarity NPC89664
0.8156 Intermediate Similarity NPC475201
0.8156 Intermediate Similarity NPC274085
0.8154 Intermediate Similarity NPC173978
0.8154 Intermediate Similarity NPC4012
0.8148 Intermediate Similarity NPC43627
0.8148 Intermediate Similarity NPC294226
0.8148 Intermediate Similarity NPC59459
0.8148 Intermediate Similarity NPC115458
0.8145 Intermediate Similarity NPC163154
0.8143 Intermediate Similarity NPC474300
0.8143 Intermediate Similarity NPC69755
0.814 Intermediate Similarity NPC91478
0.814 Intermediate Similarity NPC282577
0.814 Intermediate Similarity NPC283514
0.8134 Intermediate Similarity NPC198249
0.8134 Intermediate Similarity NPC17083
0.8134 Intermediate Similarity NPC477412
0.8129 Intermediate Similarity NPC315578
0.8129 Intermediate Similarity NPC477537
0.8125 Intermediate Similarity NPC26433
0.8125 Intermediate Similarity NPC115188
0.8125 Intermediate Similarity NPC472046
0.8125 Intermediate Similarity NPC120171
0.8125 Intermediate Similarity NPC222876
0.8125 Intermediate Similarity NPC159760
0.8125 Intermediate Similarity NPC244994
0.8125 Intermediate Similarity NPC272454
0.8125 Intermediate Similarity NPC301987
0.8125 Intermediate Similarity NPC35856
0.8125 Intermediate Similarity NPC179092
0.8125 Intermediate Similarity NPC190971
0.8125 Intermediate Similarity NPC292665
0.8125 Intermediate Similarity NPC178395
0.811 Intermediate Similarity NPC233165
0.811 Intermediate Similarity NPC184579
0.8106 Intermediate Similarity NPC324209
0.8106 Intermediate Similarity NPC71525
0.8106 Intermediate Similarity NPC181715
0.8102 Intermediate Similarity NPC272268
0.8102 Intermediate Similarity NPC475549
0.8102 Intermediate Similarity NPC474813
0.8102 Intermediate Similarity NPC193358
0.8092 Intermediate Similarity NPC240744
0.8092 Intermediate Similarity NPC131799
0.8092 Intermediate Similarity NPC167055

  Chemically structural similarity: II. Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC51037 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
0.9076 High Similarity NPD405 Clinical (unspecified phase)
0.8516 High Similarity NPD1470 Approved
0.8203 Intermediate Similarity NPD1201 Approved
0.8102 Intermediate Similarity NPD651 Clinical (unspecified phase)
0.7971 Intermediate Similarity NPD1509 Clinical (unspecified phase)
0.7874 Intermediate Similarity NPD9493 Approved
0.773 Intermediate Similarity NPD2346 Discontinued
0.7708 Intermediate Similarity NPD3300 Phase 2
0.7681 Intermediate Similarity NPD943 Approved
0.7676 Intermediate Similarity NPD970 Clinical (unspecified phase)
0.7661 Intermediate Similarity NPD9266 Approved
0.7661 Intermediate Similarity NPD74 Approved
0.766 Intermediate Similarity NPD2935 Discontinued
0.7635 Intermediate Similarity NPD3226 Approved
0.7606 Intermediate Similarity NPD1471 Phase 3
0.7606 Intermediate Similarity NPD2344 Approved
0.7581 Intermediate Similarity NPD9267 Approved
0.7581 Intermediate Similarity NPD9264 Approved
0.7581 Intermediate Similarity NPD9263 Approved
0.7554 Intermediate Similarity NPD1240 Approved
0.75 Intermediate Similarity NPD2798 Approved
0.75 Intermediate Similarity NPD447 Suspended
0.7465 Intermediate Similarity NPD1510 Phase 2
0.7463 Intermediate Similarity NPD9717 Approved
0.7448 Intermediate Similarity NPD1878 Clinical (unspecified phase)
0.7447 Intermediate Similarity NPD1607 Approved
0.7426 Intermediate Similarity NPD1164 Approved
0.7426 Intermediate Similarity NPD1203 Approved
0.741 Intermediate Similarity NPD2313 Discontinued
0.7397 Intermediate Similarity NPD2309 Approved
0.7365 Intermediate Similarity NPD4378 Clinical (unspecified phase)
0.7343 Intermediate Similarity NPD2799 Discontinued
0.7338 Intermediate Similarity NPD3882 Suspended
0.7315 Intermediate Similarity NPD1512 Approved
0.7308 Intermediate Similarity NPD9281 Approved
0.7297 Intermediate Similarity NPD7390 Discontinued
0.7293 Intermediate Similarity NPD4196 Clinical (unspecified phase)
0.7292 Intermediate Similarity NPD5408 Approved
0.7292 Intermediate Similarity NPD5404 Approved
0.7292 Intermediate Similarity NPD5406 Approved
0.7292 Intermediate Similarity NPD5405 Approved
0.7286 Intermediate Similarity NPD411 Approved
0.7259 Intermediate Similarity NPD1547 Clinical (unspecified phase)
0.7258 Intermediate Similarity NPD9261 Approved
0.7239 Intermediate Similarity NPD2932 Approved
0.7226 Intermediate Similarity NPD1876 Approved
0.7222 Intermediate Similarity NPD3299 Clinical (unspecified phase)
0.7218 Intermediate Similarity NPD9545 Approved
0.7209 Intermediate Similarity NPD1609 Clinical (unspecified phase)
0.72 Intermediate Similarity NPD164 Approved
0.72 Intermediate Similarity NPD1237 Approved
0.7194 Intermediate Similarity NPD9494 Approved
0.7192 Intermediate Similarity NPD1549 Phase 2
0.7181 Intermediate Similarity NPD1511 Approved
0.7165 Intermediate Similarity NPD9265 Clinical (unspecified phase)
0.7163 Intermediate Similarity NPD3764 Approved
0.7133 Intermediate Similarity NPD2533 Approved
0.7133 Intermediate Similarity NPD2534 Approved
0.7133 Intermediate Similarity NPD1899 Clinical (unspecified phase)
0.7133 Intermediate Similarity NPD2532 Approved
0.7133 Intermediate Similarity NPD7422 Clinical (unspecified phase)
0.7123 Intermediate Similarity NPD1550 Clinical (unspecified phase)
0.7123 Intermediate Similarity NPD1552 Clinical (unspecified phase)
0.7113 Intermediate Similarity NPD520 Approved
0.7111 Intermediate Similarity NPD3019 Approved
0.7107 Intermediate Similarity NPD6232 Discontinued
0.7099 Intermediate Similarity NPD1241 Discontinued
0.7097 Intermediate Similarity NPD289 Clinical (unspecified phase)
0.7097 Intermediate Similarity NPD7819 Suspended
0.7097 Intermediate Similarity NPD2801 Approved
0.7095 Intermediate Similarity NPD3750 Approved
0.7081 Intermediate Similarity NPD7473 Discontinued
0.7067 Intermediate Similarity NPD6799 Approved
0.7055 Intermediate Similarity NPD1551 Phase 2
0.7051 Intermediate Similarity NPD5402 Approved
0.7032 Intermediate Similarity NPD1934 Approved
0.7027 Intermediate Similarity NPD2800 Approved
0.7021 Intermediate Similarity NPD6832 Phase 2
0.7014 Intermediate Similarity NPD230 Phase 1
0.7007 Intermediate Similarity NPD2343 Clinical (unspecified phase)
0.7 Intermediate Similarity NPD1019 Discontinued
0.6992 Remote Similarity NPD288 Approved
0.6987 Remote Similarity NPD2393 Clinical (unspecified phase)
0.6978 Remote Similarity NPD1283 Approved
0.6977 Remote Similarity NPD2182 Approved
0.6962 Remote Similarity NPD7075 Discontinued
0.6957 Remote Similarity NPD9269 Phase 2
0.6957 Remote Similarity NPD3972 Approved
0.6943 Remote Similarity NPD3817 Phase 2
0.6933 Remote Similarity NPD3751 Discontinued
0.6923 Remote Similarity NPD6844 Discontinued
0.6917 Remote Similarity NPD690 Clinical (unspecified phase)
0.6912 Remote Similarity NPD9268 Approved
0.6912 Remote Similarity NPD1651 Approved
0.6911 Remote Similarity NPD844 Approved
0.6906 Remote Similarity NPD1755 Approved
0.6903 Remote Similarity NPD4380 Phase 2
0.6903 Remote Similarity NPD6599 Discontinued
0.6901 Remote Similarity NPD7879 Clinical (unspecified phase)
0.6879 Remote Similarity NPD7096 Clinical (unspecified phase)
0.6867 Remote Similarity NPD7003 Approved
0.6864 Remote Similarity NPD8150 Discontinued
0.6861 Remote Similarity NPD4626 Approved
0.6855 Remote Similarity NPD3749 Approved
0.6846 Remote Similarity NPD6831 Clinical (unspecified phase)
0.6835 Remote Similarity NPD1608 Approved
0.6835 Remote Similarity NPD2296 Approved
0.6832 Remote Similarity NPD6959 Discontinued
0.6828 Remote Similarity NPD4060 Phase 1
0.6826 Remote Similarity NPD4954 Approved
0.6826 Remote Similarity NPD4955 Approved
0.6826 Remote Similarity NPD5026 Approved
0.6826 Remote Similarity NPD5034 Approved
0.6826 Remote Similarity NPD5028 Approved
0.6826 Remote Similarity NPD36 Approved
0.6824 Remote Similarity NPD2796 Approved
0.6818 Remote Similarity NPD5403 Approved
0.681 Remote Similarity NPD6168 Clinical (unspecified phase)
0.681 Remote Similarity NPD6167 Clinical (unspecified phase)
0.681 Remote Similarity NPD6166 Phase 2
0.6806 Remote Similarity NPD3268 Approved
0.68 Remote Similarity NPD7421 Clinical (unspecified phase)
0.6797 Remote Similarity NPD5401 Approved
0.6797 Remote Similarity NPD7410 Clinical (unspecified phase)
0.6786 Remote Similarity NPD4379 Clinical (unspecified phase)
0.6767 Remote Similarity NPD7635 Approved
0.6766 Remote Similarity NPD5027 Approved
0.6766 Remote Similarity NPD5029 Approved
0.6766 Remote Similarity NPD5030 Phase 2
0.6766 Remote Similarity NPD5031 Approved
0.6763 Remote Similarity NPD1281 Approved
0.6757 Remote Similarity NPD3748 Approved
0.6757 Remote Similarity NPD4308 Phase 3
0.6755 Remote Similarity NPD8166 Discontinued
0.6739 Remote Similarity NPD3412 Clinical (unspecified phase)
0.6735 Remote Similarity NPD6651 Approved
0.6731 Remote Similarity NPD2651 Approved
0.6731 Remote Similarity NPD5808 Clinical (unspecified phase)
0.6731 Remote Similarity NPD2649 Approved
0.673 Remote Similarity NPD8443 Clinical (unspecified phase)
0.6728 Remote Similarity NPD1247 Approved
0.6714 Remote Similarity NPD4878 Approved
0.6711 Remote Similarity NPD6190 Approved
0.6709 Remote Similarity NPD6801 Discontinued
0.6707 Remote Similarity NPD6797 Phase 2
0.6691 Remote Similarity NPD3026 Approved
0.6691 Remote Similarity NPD3496 Discontinued
0.6691 Remote Similarity NPD3023 Approved
0.669 Remote Similarity NPD2797 Approved
0.6686 Remote Similarity NPD8397 Clinical (unspecified phase)
0.6667 Remote Similarity NPD6355 Discontinued
0.6667 Remote Similarity NPD3025 Approved
0.6667 Remote Similarity NPD1933 Approved
0.6667 Remote Similarity NPD5951 Approved
0.6667 Remote Similarity NPD3024 Approved
0.6667 Remote Similarity NPD3600 Clinical (unspecified phase)
0.6667 Remote Similarity NPD4750 Phase 3
0.6667 Remote Similarity NPD7251 Discontinued
0.6667 Remote Similarity NPD5038 Approved
0.6667 Remote Similarity NPD5037 Approved
0.6646 Remote Similarity NPD7411 Suspended
0.6646 Remote Similarity NPD4381 Clinical (unspecified phase)
0.6646 Remote Similarity NPD3926 Phase 2
0.6645 Remote Similarity NPD6398 Clinical (unspecified phase)
0.6645 Remote Similarity NPD4628 Phase 3
0.6644 Remote Similarity NPD6663 Approved
0.6641 Remote Similarity NPD2342 Discontinued
0.6639 Remote Similarity NPD9256 Approved
0.6639 Remote Similarity NPD9258 Approved
0.6627 Remote Similarity NPD7808 Phase 3
0.6627 Remote Similarity NPD3818 Discontinued
0.6627 Remote Similarity NPD4338 Clinical (unspecified phase)
0.6624 Remote Similarity NPD7458 Discontinued
0.6619 Remote Similarity NPD17 Approved
0.6619 Remote Similarity NPD1778 Approved
0.6618 Remote Similarity NPD6671 Approved
0.6617 Remote Similarity NPD2181 Clinical (unspecified phase)
0.6617 Remote Similarity NPD4141 Clinical (unspecified phase)
0.6614 Remote Similarity NPD3020 Approved
0.6613 Remote Similarity NPD845 Approved
0.6608 Remote Similarity NPD5036 Approved
0.6605 Remote Similarity NPD919 Approved
0.6603 Remote Similarity NPD920 Approved
0.6601 Remote Similarity NPD2354 Approved
0.66 Remote Similarity NPD6099 Approved
0.66 Remote Similarity NPD6100 Approved
0.6597 Remote Similarity NPD5736 Approved
0.6596 Remote Similarity NPD1481 Phase 2
0.6589 Remote Similarity NPD1931 Clinical (unspecified phase)
0.6589 Remote Similarity NPD1930 Approved
0.6589 Remote Similarity NPD1929 Approved
0.6588 Remote Similarity NPD8313 Approved
0.6588 Remote Similarity NPD8312 Approved
0.6587 Remote Similarity NPD7804 Clinical (unspecified phase)
0.6585 Remote Similarity NPD5711 Approved
0.6585 Remote Similarity NPD5710 Approved
0.6584 Remote Similarity NPD7768 Phase 2
0.6575 Remote Similarity NPD6798 Discontinued
0.6573 Remote Similarity NPD3266 Approved
0.6573 Remote Similarity NPD3267 Approved

  Bioactivity similarity: Similar Natural Products in NPASS

Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.

Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data